Search Results - "KRIVAN, G"
-
1
In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient’s burden
Published in Bone marrow transplantation (Basingstoke) (01-07-2013)“…This randomized-controlled trial studied the efficacy of palifermin in a chemotherapy-only, high-dose Melphalan (HDM) transplant setting, to reduce oral…”
Get full text
Journal Article -
2
P253 Safety and tolerability of SCIG 20% in patients with PIDD in europe and north america
Published in Annals of allergy, asthma, & immunology (01-11-2016)Get full text
Journal Article -
3
Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies
Published in Clinical and experimental immunology (01-01-2017)“…Summary A highly concentrated (20%) immunoglobulin (Ig)G preparation for subcutaneous administration (IGSC 20%), would offer a new option for antibody…”
Get full text
Journal Article -
4
Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors : a study on behalf of the European Group for Blood and Marrow Transplantation
Published in Blood (15-01-2000)“…Allogeneic stem cell transplantation is the only treatment that can restore a normal hematopoiesis in Fanconi anemia (FA). In this retrospective multicenter…”
Get full text
Journal Article -
5
An open, prospective trial investigating the pharmacokinetics and safety, and the tolerability of escalating infusion rates of a 10% human normal immunoglobulin for intravenous infusion (IVIg), BT090, in patients with primary immunodeficiency disease
Published in Vox sanguinis (01-10-2015)“…Background and Objectives Pharmacokinetics, safety and tolerability of escalating infusion rates of BT090, a 10% intravenous immunoglobulin (IVIg), were…”
Get full text
Journal Article -
6
-
7
-
8
Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey
Published in Transplant infectious disease (01-04-2008)“…: Invasive mycoses are pre‐eminent causes of morbidity and mortality in the allogeneic stem cell transplant setting. In spite of novel diagnostic modalities,…”
Get full text
Journal Article -
9
1834 Subcutaneous Human Hepatits B Immunoglobulin (Fovepta) in Neonates of HBV-Carrier Mothers
Published in Archives of disease in childhood (01-10-2012)“…Background and Aims Postnatal active and passive immunization is recommended for prevention of hepatits-B-virus (HBV) transmission in any offspring of a…”
Get full text
Journal Article -
10
P308: NOVEL COPY NUMBER ABERRATION‐BASED CLASSIFICATION METHODS REFINE RISK ASSESSMENT IN PEDIATRIC B‐CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
Published in HemaSphere (23-06-2022)Get full text
Journal Article -
11
Allogeneic stem cell transplantation for Fanconi Anaemia
Published in Bone marrow transplantation (Basingstoke) (01-04-1998)“…Fanconi anaemia is a hereditary disorder characterised by chromosomal breaks increased by cross-linking agents. Bone marrow transplantation is the treatment of…”
Get full text
Journal Article Conference Proceeding -
12
Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study
Published in Journal of allergy and clinical immunology (01-06-2019)“…CD40 ligand (CD40L) deficiency, an X-linked primary immunodeficiency, causes recurrent sinopulmonary, Pneumocystis and Cryptosporidium species infections…”
Get full text
Journal Article -
13
Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP study
Published in Bone marrow transplantation (Basingstoke) (01-08-2020)“…Although most children with acute lymphoblastic leukemia (ALL) receive fractionated total body irradiation (FTBI) as myeloablative conditioning (MAC) for…”
Get full text
Journal Article -
14
Anti-TNF-alpha-induced anti-phospholipid syndrome manifested as necrotizing vasculitis
Published in Scandinavian Journal of Rheumatology (01-03-2010)Get full text
Journal Article -
15
Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT)
Published in Bone marrow transplantation (Basingstoke) (01-09-2020)“…Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative procedure in patients with Shwachman–Diamond syndrome (SDS) with bone marrow…”
Get full text
Journal Article -
16
Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients
Published in Journal of clinical immunology (01-11-2022)“…Warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome (WS) is a combined immunodeficiency caused by gain-of-function mutations in the…”
Get full text
Journal Article -
17
PersonALL: a genetic scoring guide for personalized risk assessment in pediatric B-cell precursor acute lymphoblastic leukemia
Published in British journal of cancer (24-08-2023)“…Background Recurrent genetic lesions provide basis for risk assessment in pediatric acute lymphoblastic leukemia (ALL). However, current prognostic classifiers…”
Get full text
Journal Article -
18
Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency
Published in The journal of allergy and clinical immunology in practice (Cambridge, MA) (01-07-2019)“…Although autoimmunity and hyperinflammation secondary to recombination activating gene (RAG) deficiency have been associated with delayed diagnosis and even…”
Get full text
Journal Article -
19
Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021
Published in Frontiers in immunology (16-12-2022)“…The J Project (JP) physician education and clinical research collaboration program was started in 2004 and includes by now 32 countries mostly in Eastern and…”
Get full text
Journal Article -
20
Correction: Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP study
Published in Bone marrow transplantation (Basingstoke) (01-10-2021)Get full text
Journal Article